FluoGuide
Manufacturing · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ole Maaløes Vej 3, København N, Capital ...Phone Number
+45 31314373Website
www.fluoguide.comRevenue
$9.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About FluoGuide
FluoGuide A/S is a clinical stage biotechnology company dedicated to enhancing surgical outcomes for cancer patients by developing fluorescent drugs that illuminate cancerous tissues. Their lead product, FG001, has shown promise in clinical trials for aggressive brain and head and neck cancers, potentially reducing surgical complications and healthcare costs. The company aims to light up 80% of solid cancers through its innovative pipeline, which includes photothermal therapy to selectively destroy cancer cells. FluoGuide is committed to driving innovation that benefits patients, society, and shareholders.Explore more
FluoGuide Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FluoGuide your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at FluoGuide
Earning: See what the market has to say on FluoGuide recently announced quarterly report
Product Launch: Get notified when FluoGuide launches new products
Click to see if FluoGuide had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if FluoGuide has recently received funding, and reach out quickly before it becomes old news!
Check out if FluoGuide is spiking on competitors!
FluoGuide, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once FluoGuide has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
FluoGuide is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
FluoGuide is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about FluoGuide.
FluoGuide Tech Stack
A closer look at the technologies used by FluoGuide
See more technologies
Most Recent Scoops
Person-Based
Partnership, Medical Research, Clinical Operations
Person-Based
Partnership, Product Development
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
FluoGuide News & Media
FluoGuide Raises SEK 12 million through Exercise of Warrants | BioSpace
FluoGuide A/S, a pioneer in the cutting-edge field of precision cancer surgery, announced the status of the exercised warrants, issued in connection with the directed share issue in July this year, raising SEK 12 million.FluoGuide releases positive interim result of FG001 in head and neck cancer
Copenhagen, Denmark, 9 January 2023 - FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce the positive interim result of FG001 in head and neck cancer that FG001 lights up in 4 out of 4 patients following the interim evaluation of the first four patients dosed in the ongoing explorative phase IIa trial in patients with head and neck squamous cell carcinomas (HNSCC) undergoing surgery. Detection of light was made from the tissue identifiedFluoGuide A/S publishes interim report for the period January – September 2022
Copenhagen, Denmark, 24 November 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 30 September 2022. The Q3 report is available as an attached document to this press release and on FluoGuide’s website: Filings & reports - FluoGuide A/S (https://fluoguide.com/investor/filings-reports/) In Q3 2022, FluoGuide made important progress and received approvals from Danish authorities to initiate the clinical phase IIb trial with FG001 in aggressivFluoGuide has enrolled the first patient in the phase IIa trial in head and neck cancer
Copenhagen, Denmark, 21 November 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the company has enrolled the first patient in the phase IIa trial with FG001 in head and neck cancer. The ongoing phase IIa trial is conducted in collaboration with Department of Otolaryngology, Head & Neck Surgery and Audiology at the University Hospital, Rigshospitalet in Denmark. The phase IIa trial is designed to obtain proof-of-concept in head and neck
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FluoGuide
Sign Up For FreeTo access detailed company insights
FluoGuide A/S is a clinical stage biotechnology company dedicated to enhancing surgical outcomes for cancer patients by developing fluorescent drugs that illuminate cancerous tissues. Their lead product, FG001, has shown promise in clinical trials for aggressive brain and head and neck cancers, potentially reducing surgical complications and health... Read More
